Health and Life Sciences
Drug discovery and design, precision/personalized medicine, medtech, biotech, diagnostics, biomedical engineering, nutrition, human physiology
With its world-class universities, strong intellectual property protection and strategic location at the heart of Europe, Switzerland has become the preferred destination for global and regional pharmaceutical headquarters. These companies benefit from the cluster's extensive expertise across the entire value chain, encompassing the development, production and marketing of new products and services - all conveniently located in one place! The combination of state-of-the-art research facilities and a highly advanced healthcare system, which demands innovative solutions, makes Switzerland an extremely attractive location for research and development.
Switzerland Innovation is your gateway to the dynamic world of Swiss innovation in the life sciences. Our ecosystem offers you a platform for collaboration, access to state-of-the-art facilities and the opportunity to shape the future of healthcare.
Our expertise spans diverse areas of the life sciences, including biomedical engineering, medical device development, diagnostics, imaging, nutrition and bioinformatics. Through interdisciplinary collaboration and state-of-the-art facilities, we foster cutting-edge research, encourage innovation and support the development of new technologies that have a positive impact on human health and well-being.
What are particle accelerators and how do they help create new products?
What are particle accelerators and how do they help create new products?Read more
We are used to thinking of particle accelerators as pure research instruments. There are however over 30'000 of them in the world and they are widely used by different industries, from med-tech and computer industry to food and security industries. Accelerator and related technologies are in the origin of many innovations.
Stimulating the Human Body's Self-Healing Powers
Stimulating the Human Body's Self-Healing PowersRead more
Drug Discovery Made in Switzerland
Drug Discovery Made in SwitzerlandRead more
Drug discovery has come a long way from guess work to a structural and targeted approach to finding new and better remedies. To develop new drugs, companies need to stay up to date about the latest discoveries in genomics, proteomics, structural or quantitative biology.
Structure-based Drug Discovery Drives the Development of Novel Treatment Options
Structure-based Drug Discovery Drives the Development of Novel Treatment OptionsRead more
Founding a startup is a rendezvous with reality
Founding a startup is a rendezvous with realityRead more
Calciscon develops and markets the first and only diagnostic blood test to measure the likelihood of calcification in the blood. Kidney patients often have heightened levels of calcification. The Calciscon test offers new diagnostic, treatment and prognosis options.
PROTON THERAPYRead more
This breakthrough technology for deep-seated tumor irradiation has become one of the leading forms of tumor and cancer treatment around the world. With proton therapy, tumor tissues are destroyed using protons.
Virtual Reality Specto VR
Virtual Reality Specto VRRead more
Medical Application of Virtual and Augmented Reality Tools. With the Virtual Reality tool SpectoVR, doctors can interact in a three-dimensional space with the patient data prior to surgery.
The MIRACLE Project
The MIRACLE ProjectRead more
MIRACLE, short for Minimally Invasive Robot-Assisted Computer-guided LaserosteotomE, aims to develop a robotic endoscope to perform contact-free bone surgery with laser light.
Electron Diffraction for Drug Discovery
Electron Diffraction for Drug DiscoveryMore Details
Modern pharmaceutical development is tailored to the chemical and physical characteristics of active organic compounds. Obtaining a polymorph portfolio of a compound is a demanding process. With its advantages, electron diffraction represents one of the most promising fields of research for unlocking new possibilities in structure-based drug discovery.
Unprecedented level of detection
Unprecedented level of detectionRead more
The results of the research and development activities in chemical, pharmaceutical and many other areas often depend on the correctly identified structure of the analyzed sample. X-Ray Powder Diffraction (XRPD) is considered the gold standard method for identifying and quantifying crystalline solid forms and provides the industry with crucial data.
Novel ligand-bound GPCR structures
Novel ligand-bound GPCR structuresRead more
Membrane protein drug targets represent a significant challenge for high-resolution three-dimensional structure determination limiting the discovery and development of novel medicines. leadXpro AG, a company at PARK INNOVAARE, successfully tackles the membrane protein structure identification challenge to advance the drug discovery process and bring better drugs to the market.
The value of the absolute structure
The value of the absolute structureMore Details
The exact knowledge and understanding of a molecule’s structure underpin all the substantial progress in chemical and pharmaceutical research. Using state-of-the-art technologies at the Paul Scherrer Institute (PSI), the company Crystallise! has achieved unprecedented results in absolute configuration determination of a small single crystal of a light atom compound.
Breath test for detecting head and neck Cancer
Breath test for detecting head and neck CancerRead more
Inhale, then exhale. This simple act could now save lives. A technology developed in part at EPFL can quickly identify the presence of a head and neck cancer, such as of the throat or mouth by analysing people's breath. The new device, equipped with extremely sensitive sensors, has been tested on patients and operates with a computer or even a mobile phone.
Better and cheaper DNA sequencing
Better and cheaper DNA sequencingRead more
EPFL scientists have developed a method that improves the accuracy of DNA sequencing up to a thousand times. The method, which uses nanopores to read individual nucleotides, paves the way for better – and cheaper – DNA sequencing. Reading the exact make-up of genes, scientists can detect mutations, or even identify different organisms.
Innovative Cancer Immunotherapy
Innovative Cancer ImmunotherapyRead more
IPS Biopharma is a biotech company developing a proprietary drug for use in the innovative cancer immunotherapy inCVAX for the treatment of solid metastatic tumors.